Population
In vitro models of HIV-1 TAR RNA and Tat protein
Comparison
Mutations in TAR RNA vs Wild-type TAR RNA
Design
Preclinical
Authors
Loading...
May guide TAR-targeted antivirals; leaves open validation in cellular and animal HIV models.
Identifies the specific 3-nucleotide bulge in HIV-1 TAR RNA required for Tat binding and trans-activation, providing mechanistic insights into viral replication.
Roy et al. (1990) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: